Efficacy and Safety of Ipragliflozin (IPRA) in Japanese Patients with Type 2 Diabetes Mellitus (T2DM) Stratified by Body Mass Index (BMI)

被引：0
|
作者：
Kashiwagi, Atsunori
Yoshida, Satoshi
Nakamura, Ichiro
Kazuta, Kenichi
Ueyama, Eiji
Takahashi, Hideyuki
Satomi, Hayato
Kosakai, Yoshinori
Kawamuki, Kousei
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1197-P
引用
收藏
页码：A309 / A309
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Ipragliflozin in Japanese Type 2 Diabetic Patients
    Takihata, Masahiro
    Terauchi, Yasuo
    DIABETES, 2015, 64 : A311 - A311
  • [22] Efficacy of metformin alone or in combination with insulin in pediatric patients with type 2 diabetes mellitus (T2DM)
    Weinzimer, SA
    McKnight, WJ
    Murphy, K
    Jawad, AF
    Celona-Jacobs, N
    Haque, A
    Katz, LEL
    DIABETES, 2001, 50 : A68 - A68
  • [23] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [24] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [25] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [26] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    FASEB JOURNAL, 2002, 16 (04): : A208 - A208
  • [27] Efficacy and Safety of Canagliflozin (CANA) Monotherapy in Subjects With Type 2 Diabetes Mellitus (T2DM) Over 52 Weeks
    Stenloef, Kaj
    Cefalu, William T.
    Kim, Kyoung-Ah
    Jodar, Esteban
    Alba, Maria
    Edwards, Robert
    Tong, Cindy
    Canovatchel, William
    Meininger, Gary
    DIABETES, 2013, 62 : A303 - A303
  • [28] TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) WITH SITAGLIPTIN-EFFICACY AND SAFETY IN A REAL-LIFE SETTING
    Kusterer, K.
    Ruessmann, H. J.
    Hens, C.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 : 52 - 52
  • [29] Efficacy and Safety of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) for Type 2 Diabetes Mellitus (T2DM)
    Ford, Daniel M.
    Baz-Hecht, Merav
    Said, Nabil A.
    Tao, Ben
    Truitt, Kenneth E.
    Chou, Hubert S.
    DIABETES, 2013, 62 : A273 - A273
  • [30] Cardiovascular safety of dapagliflozin in type 2 diabetes mellitus (T2DM) patients with various degrees of cardiovascular risk
    Sonesson, C.
    Frederich, R.
    Johansson, P. A.
    Gause-Nilsson, I.
    Langkilde, A. M.
    List, J. F.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1072 - 1072
12345